Development of Vaccines, Therapeutics and Prophylaxis against Coronaviral Infection
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Vaccines and Therapeutic Developments".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 50
Special Issue Editor
Special Issue Information
Dear Colleagues,
SARS-CoV-2, the etiological agent behind COVID-19 infection, has taken immeasurable tolls around the globe. These extend beyond the mortality and morbidity associated with both acute and chronic viral infections, with major impacts economically, societally, and on individuals’ mental health globally. Some semblance of normalcy is returning, largely due to advancements in immunization and treatment options against SARS-CoV-2. Between waning immunity and novel variants capable of escaping neutralizing antibodies, this is an area of continued research interest.
This Special Issue is focused on the continued research and development of novel vaccines, therapeutics, and prophylaxis, which might prove invaluable in terms of future pandemic preparedness, whether for emerging SARS-CoV-2 variants or other coronaviruses with high zoonotic potential. You are invited to submit original articles and review articles related to this topic.
Dr. Tyler M. Renner
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- SARS-CoV-2
- coronavirus
- vaccines
- therapeutic
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
